S

Systimmune

Develops bispecific antibodies and ADCs

Clinical Scientist

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timePrinceton, NJ, USA$80k - $130k /yrIn-person

About the Job

Requirements

  • A degree in a life sciences or health-related field.
  • At least 3–4 years of industry experience; clinical research experience is preferred.
  • Expertise in oncology therapeutic areas.
  • Experience with data cleaning, visualization, and basic statistical analysis; Excel is mandatory and R is optional.
  • Knowledge of International Council for Harmonisation (ICH), Good Clinical Practice (GCP), and other relevant regulatory guidelines.
  • Ability to analyze, interpret, and communicate data to internal and external stakeholders.
  • Ability to collaborate effectively with medical experts.

Responsibilities

  • Monitor, review, and summarize safety and efficacy data in one or more ongoing studies on a regular basis.
  • Collaborate with the clinical team to translate clinical protocols and amendments into operational deliverables, including ongoing clinical study data review and analysis, and prepare or review study plans such as Medical Monitoring, Medical Data Review, Safety Management, and CRF Completion Guidelines.
  • Respond to study questions from sites and vendors, with supervision from the study medical monitor or Clinical Development as needed.
  • Search for, critically review, and summarize relevant scientific, drug development, and medical literature to support new clinical trial design and the development of clinical or regulatory documents.
  • Support preparation of scientific material.
  • Contribute to developing SOPs and associated guidelines and templates.
  • Participate in cross-functional team meetings with clinical operations, safety, regulatory, biostatistics, and data management.

Desired Qualifications

  • Clinical research industry experience.

About the Company

Systimmune

Develops bispecific antibodies and ADCs

Systimmune is a biopharmaceutical company that develops antibody-based cancer therapies, including bispecific and trispecific antibodies and antibody-drug conjugates (ADCs). These products are designed to act on the solid tumor micro-environment to directly attack tumors and/or to activate the immune system to fight cancer. The company uses multiple immuno-oncology platforms and experienced scientists to create biologics that intervene in the tumor environment in systematic ways. Compared with competitors, Systimmune emphasizes integrating several antibody-based modalities (bispecifics, trispecifics, and ADCs) and a deep focus on the solid tumor micro-environment, aiming to translate biological insight into targeted, immune-engaging therapies. The goal is to produce biologics that effectively modulate the tumor environment and mobilize the body's own immune response to destroy cancer cells.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
Redmond, WA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Systimmune

See more jobs